Prelude Capital Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,782
| Closed | -$405K | – | 1322 |
|
|
2024
Q4 | $405K | Sell |
30,782
-13,618
| -31% | -$179K | 0.03% | 570 |
|
|
2024
Q3 | $498K | Buy |
44,400
+6,200
| +16% | +$69.5K | 0.03% | 558 |
|
|
2024
Q2 | $411K | Buy |
+38,200
| New | +$411K | 0.03% | 563 |
|
|
2024
Q1 | – | Sell |
-21,509
| Closed | -$390K | – | 1369 |
|
|
2023
Q4 | $390K | Buy |
+21,509
| New | +$390K | 0.03% | 530 |
|
|
2023
Q3 | – | Sell |
-13,206
| Closed | -$239K | – | 1169 |
|
|
2023
Q2 | $239K | Buy |
+13,206
| New | +$239K | 0.02% | 656 |
|